South San Francisco, California, April 12— T-Rex Bio, a discovery-stage biotechnology company, has hired Christopher Yohn as the Head of Computational Biology. The company is dedicated to discovering and developing a new class of immuno-regulatory therapeutics which reset the immune system to restore health with regulatory T cells (T-regs).
Dr. Yohn joins T-Rex from UNITY Biotechnology, where he served as Senior Director of Discovery Technologies after being promoted from director roles in bioinformatics and biomarkers. Dr. Yohn previously had stints at Sapphire Energy and Farville. He received his Ph.D. at Scripps Research before completing his postdoc at The Skirball Institute at NYU Medical Center. Dr. Yohn has published over 20 articles and has 7 patents issued or pending.